Gulf Breeze

Resilience Network


You are here

Policy

Billions in Hospital Virus Aid Rested on Compliance With Private Vendor --NY Times

WASHINGTON — The Trump administration tied billions of dollars in badly needed coronavirus medical funding this spring to hospitals’ cooperation with a private vendor collecting data for a new Covid-19 database that bypassed the Centers for Disease Control and Prevention.

The highly unusual demand, aimed at hospitals in coronavirus hot spots using funds passed by Congress with no preconditions, alarmed some hospital administrators and even some federal health officials.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

WHO says plasma therapy still ‘experimental’ --plus other developments

GENEVA — The World Health Organization says using plasma from the recovered to treat COVID-19 is still considered an “experimental” therapy and that the preliminary results showing it may work are still “inconclusive.”

President Donald Trump on Sunday approved an emergency authorization of convalescent plasma for COVID-19 patients.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Trump announces plasma treatment authorized for COVID-19

WASHINGTON (AP) — After expressing frustration at the slow pace of approval for coronavirus treatments, President Donald Trump announced Sunday the emergency authorization of convalescent plasma for COVID-19 patients.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

How Feds Decide On Remdesivir Shipments To States Remains Mysterious

By the second week in July, COVID-19 cases in North Carolina were climbing fast.

With nearly 19,000 diagnoses over the previous two weeks, only five states recorded more new coronavirus cases than North Carolina did.

"Today is our highest day of hospitalizations and our second-highest day of cases," Gov. Roy Cooper, a Democrat, announced on July 9, standing behind a podium in the state's Emergency Operations Center. "Please continue to treat the virus like the deadly threat that it is."

One of the few treatment options for patients seriously ill with COVID-19 is the antiviral drug remdesivir. Authorized by the Food and Drug Administration in May for emergency use in the pandemic, remdesivir is in short supply. The federal government has taken on the responsibility for deciding where vials of the medicine should go.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Policy
howdy folks